Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1-18
JournalViruses
StatePublished - Dec 31 2020

Fingerprint

Dive into the research topics of 'Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval'. Together they form a unique fingerprint.

Cite this